Revvity to Present at BofA Securities 2024 Health Care Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Revvity Inc (RVTY) PT Lowered to $120 at UBS
April 29, 2024 12:23 PM EDTUBS analyst Dan Leonard lowered the price target on Revvity Inc (NYSE: RVTY) to $120.00 (from $125.00) while maintaining a Neutral rating.
The analyst comments "Q1 results came in ahead of expectation with 3% organic revenue decline, largely driven by stronger performance in Software, ImmunoDx and newborn... More
